Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study
X Yang, Y Yu, J Xu, H Shu, H Liu, Y Wu… - The lancet respiratory …, 2020 - thelancet.com
Background An ongoing outbreak of pneumonia associated with the severe acute respiratory
coronavirus 2 (SARS-CoV-2) started in December, 2019, in Wuhan, China. Information …
coronavirus 2 (SARS-CoV-2) started in December, 2019, in Wuhan, China. Information …
[HTML][HTML] Thrombocytopenia and its association with mortality in patients with COVID‐19
X Yang, Q Yang, Y Wang, Y Wu, J Xu, Y Yu… - Journal of Thrombosis …, 2020 - Elsevier
Background Severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2), which
causes novel coronavirus disease 2019 (COVID‐19), is spreading rapidly around the world. …
causes novel coronavirus disease 2019 (COVID‐19), is spreading rapidly around the world. …
[HTML][HTML] Clinical course and predictors of 60-day mortality in 239 critically ill patients with COVID-19: a multicenter retrospective study from Wuhan, China
Background The global numbers of confirmed cases and deceased critically ill patients with
COVID-19 are increasing. However, the clinical course, and the 60-day mortality and its …
COVID-19 are increasing. However, the clinical course, and the 60-day mortality and its …
[PDF][PDF] Plasma proteomics identify biomarkers and pathogenesis of COVID-19
T Shu, W Ning, D Wu, J Xu, Q Han, M Huang, X Zou… - Immunity, 2020 - cell.com
The coronavirus disease 2019 (COVID-19) pandemic is a global public health crisis. However,
little is known about the pathogenesis and biomarkers of COVID-19. Here, we profiled …
little is known about the pathogenesis and biomarkers of COVID-19. Here, we profiled …
[HTML][HTML] Patients with COVID-19 in 19 ICUs in Wuhan, China: a cross-sectional study
Y Yu, D Xu, S Fu, J Zhang, X Yang, L Xu, J Xu, Y Wu… - Critical care, 2020 - Springer
Background A COVID-19 outbreak started in Wuhan, China, last December and now has
become a global pandemic. The clinical information in caring of critically ill patients with COVID-…
become a global pandemic. The clinical information in caring of critically ill patients with COVID-…
[PDF][PDF] Plasma metabolomic and lipidomic alterations associated with COVID-19
…, M Huang, Y Yu, Q Yang, T Zhu, J Xu… - National Science …, 2020 - academic.oup.com
The pandemic of the coronavirus disease 2019 (COVID-19) has become a global public
health crisis. The symptoms of COVID-19 range from mild to severe, but the physiological …
health crisis. The symptoms of COVID-19 range from mild to severe, but the physiological …
Elevated MCU expression by CaMKIIδB limits pathological cardiac remodeling
…, S Xu, J Xu, Y Xin, Y Lu, H Zhang, B Zhou, H Xu… - Circulation, 2022 - Am Heart Assoc
Background: Calcium (Ca 2+ ) is a key regulator of energy metabolism. Impaired Ca 2+
homeostasis damages mitochondria, causing cardiomyocyte death, pathological hypertrophy, …
homeostasis damages mitochondria, causing cardiomyocyte death, pathological hypertrophy, …
[HTML][HTML] MDSCs in sepsis-induced immunosuppression and its potential therapeutic targets
Sepsis is a life-threatening organ dysfunction caused by a dysregulated host response to
infection. In sepsis, a complicated immune response is initiated, which varies over time with …
infection. In sepsis, a complicated immune response is initiated, which varies over time with …
[HTML][HTML] A novel risk-stratification models of the high-flow nasal cannula therapy in COVID-19 patients with hypoxemic respiratory failure
Background: High-flow nasal cannula (HFNC) has been recommended as a suitable choice
for the management of coronavirus disease 2019 (COVID-19) patients with acute …
for the management of coronavirus disease 2019 (COVID-19) patients with acute …
[PDF][PDF] NLRC3 expression in macrophage impairs glycolysis and host immune defense by modulating the NF-κB-NFAT5 complex during septic immunosuppression
J Xu, C Gao, Y He, X Fang, D Sun, Z Peng, H Xiao… - Molecular Therapy, 2023 - cell.com
Impairment of innate immune cell function and metabolism underlies immunosuppression in
sepsis; however, a promising therapy to orchestrate this impairment is currently lacking. In …
sepsis; however, a promising therapy to orchestrate this impairment is currently lacking. In …